This preliminary prospectus supplement relates to an effective registration statement under the Securities Act of 1933, as amended, but is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities and they are not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
Filed Pursuant to Rule 424(b)(2)
Registration No. 333-240269
SUBJECT TO COMPLETION
PRELIMINARY PROSPECTUS SUPPLEMENT, DATED OCTOBER 29, 2021
Prospectus Supplement
(To Prospectus dated October 26, 2021)
€
Highland Holdings S.à r.l.
€ % Notes due 20
€ % Notes due 20
€ % Notes due 20
Fully and Unconditionally Guaranteed by
Otis Worldwide Corporation
Highland Holdings S.à r.l. (“Highland” or the “Issuer”) a private limited liability company (société à responsabilité limitée) incorporated and existing under the laws of Grand Duchy of Luxembourg (“Luxembourg”), having its registered office at 6, rue Jean Monnet, L-2180 Luxembourg, and registered with Luxembourg Trade and Companies Register (Registre de Commerce et des Sociétés, Luxembourg) under number B237108, is offering three series of fixed rate notes consisting of (i) € aggregate principal amount of its % Notes due 20 (the “20 Notes”), (ii) € aggregate principal amount of its % Notes due 20 (the “20 Notes”) and (iii) € aggregate principal amount of its % Notes due 20 (the “20 Notes” and, together with the 20 Notes and the 20 Notes, the “Notes”). Interest on the 20 Notes will be payable on of each year, beginning , 2022. Interest on the 20 Notes will be payable on of each year, beginning , 2022. Interest on the 20 Notes will be payable on of each year, beginning , 2022. The 20 Notes will mature on , 20 , the 20 Notes will mature on , 20 and the 20 Notes will mature on , 20 .
Each series of Notes will be fully and unconditionally guaranteed on an unsecured, unsubordinated basis by Otis Worldwide Corporation (“Otis”) (Otis’ guarantee of each such series, a “Parent Guarantee” and, collectively, the “Parent Guarantees”).
The Notes and the Parent Guarantees will be unsecured, unsubordinated obligations of the Issuer and Otis, respectively, and will rank equally in right of payment with all of the Issuer’s and Otis’ respective existing and future unsecured, unsubordinated indebtedness. The Notes will be issued in minimum denominations of €100,000 and any integral multiple of €1,000 in excess thereof.
The Issuer may redeem any series of Notes, in whole or in part, at any time at the applicable redemption price described under the caption “Description of the Notes—Optional Redemption.” In addition, the Notes may be redeemed in whole but not in part, at any time at the Issuer’s option in the event of certain developments affecting the tax laws of Luxembourg, the United States or another relevant taxing jurisdiction. See “Description of the Notes—Redemption for Tax Reasons.” Upon the occurrence of a Change of Control Triggering Event (as defined in the “Description of the Notes—Certain Definitions”), unless the Issuer has exercised its right to redeem the Notes by giving irrevocable notice on or prior to the 30th day after the Change of Control Triggering Event in accordance with the Indenture (as defined in the “Description of the Notes”), each holder of the Notes will have the right to require the Issuer to purchase all or a portion of such holder’s Notes at a purchase price equal to 101% of the principal amount thereof, plus accrued and unpaid interest, if any, to, but excluding, the Change of Control Payment Date (as defined in the “Description of the Notes—Offer to Purchase Upon Change of Control Triggering Event”).
On September 23, 2021, Otis announced its intention to acquire all of the issued and outstanding shares of Zardoya Otis, S.A. (“Zardoya”) not owned by Otis or its subsidiaries in an all-cash voluntary tender offer at a price of €7.00 per share in cash and delist Zardoya from the Madrid, Barcelona, Bilbao and Valencia stock exchanges (the “Tender Offer”). The price per share to be paid in the Tender Offer was adjusted to €6.93 as a result of the dividend paid by Zardoya on October 11, 2021. The Issuer intends to use the net proceeds of the offering of the Notes to purchase shares of Zardoya, whether pursuant to the Tender Offer or otherwise, and to pay fees and expenses in connection therewith. If the Tender Offer and Otis’ purchase of shares of Zardoya do not ultimately require all of the offering proceeds, Otis will determine how such proceeds may be used going forward; such uses may include, but are not limited to, general corporate purposes, acquisitions or the repayment of debt.
The Issuer currently expects, shortly after consummation of the offering, to contribute as equity a portion of the net proceeds of the offering to Opal Spanish Holdings, S.A.U. (“Opal”), Otis’ indirect, wholly-owned subsidiary conducting the Tender Offer, and lend Opal the balance of the net proceeds. Subject to the terms and conditions thereof, the consummation of the Tender Offer will occur after the completion of this offering. The Tender Offer is not contingent on the offering of the Notes described in this prospectus supplement, nor is the offering of the Notes described in this prospectus supplement contingent on the Tender Offer. See “Summary—Recent Developments—Tender Offer for Zardoya”, “Use of Proceeds” and “Cautionary Note Regarding Forward-Looking Statements.”
Each series of Notes constitutes a new issue of securities for which there is no established trading market. We intend to apply to list the Notes on the New York Stock Exchange (the “NYSE”). The listing application will be subject to approval by the NYSE. If such a listing is obtained, we have no obligation to maintain it, and we may delist the Notes at any time. Currently, there is no public market for the Notes.
Investing in the Notes involves certain risks. You should read this prospectus supplement and the accompanying prospectus, including the documents incorporated by reference herein and therein, carefully before you make your investment decision. See “
Risk Factors” beginning on page S-
8 of this prospectus supplement and “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2020, and our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2021, each of which is incorporated by reference herein, for more information.
Public offering price(1) | | | % | | | € | | | % | | | € | | | % | | | € |
Underwriting discount | | | % | | | € | | | % | | | € | | | % | | | € |
Proceeds to Otis (before expenses) | | | % | | | € | | | % | | | € | | | % | | | € |
(1)
| Plus accrued interest, if any, from , 2021, if the Notes are delivered after that date. |
None of the Securities and Exchange Commission (the “SEC”), the Luxembourg Financial Sector Supervisory Authority (the Commission de Surveillance du Secteur Financier) (the “CSSF”) or any other regulatory body has approved or disapproved of the Notes or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
The underwriters expect to deliver the Notes to purchasers through the book-entry delivery system of Euroclear Bank S.A./N.V. (“Euroclear”) and Clearstream Banking S.A., société anonyme (“Clearstream”), on or about November , 2021, which is the fifth business day following the date of this prospectus supplement. This settlement date may affect the trading of the Notes.
Joint Book-Running Managers
Morgan Stanley | | | HSBC | | | J.P. Morgan |
The date of this prospectus supplement is , 2021.